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A 56-year-old patient with severe pulmonary hypertension developed severe tricuspid regurgitation, right-sided heart failure,
and congestive hepatopathy. She was transferred for possible lung transplant and/or tricuspid valve surgery. Clinical and
echocardiographic assessment provided conﬁdence that acute tricuspid valve failure was responsible for the decompensation and
that tricuspid valve replacement despite pulmonary hypertension could be performed.
Copyright © 2009 Jamil A. Aboulhosn et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. Case Presentation
A-56-year old Hispanic female with idiopathic pulmonary
arterial hypertension (PAH) for 13 years was stable (WHO
class II) on subcutaneous treprostinil for 8 years. In 1999,
diagnostic right heart catheterization had shown elevated
right atrial (mean 20mmHg) and pulmonary artery (PA)
pressure (145/42mmHg) with normal pulmonary capillary
wedge pressure (10mmHg). The patient began complaining
of fatigue, lethargy, and dyspnea on minimal exertion in
January 2007 and was admitted in February for syncope,
anorexia, abdominal pain, jaundice, and decreasing urine
output.Anechocardiogramrevealedrightventricularhyper-
trophy with severe tricuspid regurgitation (TR) and pre-
served right ventricular (RV) systolic function. In May 2007
she was admitted to an outside hospital for persistent symp-
toms and resistant volume overload. Physical examination
demonstrated jaundice, ascites, and right heart failure. Her
jugular venous pressure was 18cm H2O. A systolic RV heave
was present. There was a 3/6 holosystolic murmur at the left
sternal border, a loud pulmonary component of the second
heartsoundandanRVS4gallop.Thepatientwasmoderately
hypotensive(systolicbloodpressureof80mmHg),androom
air oxygen saturation was 93%. An echocardiogram demon-
stratedsevereTRwithaﬂailanteriorleaﬂet(Figure 1),which
was not previously noted. Estimated PA pressure had fallen
to 2/3 of systemic (Figure 2(a)). M-mode echocardiography
demonstrated diastolic leftward septal motion consistent
with RV volume overload (Figure 3). RV systolic function
was unchanged, and there was no TV annular dilation.
Retrospective review of hepatic function aroused sus-
picion for acute decompensated RV failure with conges-
tive hepatopathy occurring several months earlier, possibly
related to the ﬂail tricuspid leaﬂet. Upon review of an
echocardiogram performed three months prior, the ﬂail
tricuspid leaﬂet was indeed found to be present. Because
of the temporal relationship between the severe TR and
worsening symptoms as well as RV failure and hepatic
dysfunction despite preserved RV systolic function, it was
felt that tricuspid valve (TV) failure alone could explain the
patient’s symptoms and that TV repair or replacement might
beneﬁt the patient.
The patient was continued on subcutaneous treprostinil










Figure 1: (a) Transthoracic 2D echo parasternal long-axis systolic view of a ﬂail anterior tricuspid valve leaﬂet (TV). Right atrium (RA) and
right ventricle (RV) are labeled. The tricuspid valve annulus is not dilated, measuring 3cm in maximum diameter. (b) Color ﬂow Doppler
demonstrating severe tricuspid regurgitation (TR).
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Figure 2: (a) Continuous wave Doppler proﬁle of tricuspid regurgitation in the parasternal long-axis view. The tricuspid valve regurgitant
velocity is 3.61m/s. Using the modiﬁed Bernoulli equation (ΔP = 4V2) and assuming a right atrial pressure of 15mmHg, the estimated
pulmonary artery systolic pressure is 67mmHg. (b) Tissue Doppler proﬁle of the tricuspid valve annulus demonstrates a systolic velocity of
14.5cm/sec consistent with preserved right ventricular function [1, 2].
transferred to our institution for evaluation for possible
lung transplant and/or TV surgery. Repeat right heart
catheterization demonstrated elevated right atrial pressures
(V = 35mmHg, mean = 21mmHg), moderately elevated
PA pressure (64/29mmHg), pulmonary capillary wedge
pressure at upper limits of normal (mean 16mmHg),
decreased cardiac index by thermodilution (1.7L/min/m2),
and elevated pulmonary vascular resistance (7.1 Wood
Units). Chest CT demonstrated marked dilation of the
main and proximal branch pulmonary arteries with mural
calciﬁcation and a moderate pericardial eﬀusion. Ventila-
tion/perfusion scan showed low probability for thromboem-
bolism. Laboratories showed platelet count of 58000/µL,
total bilirubin of 3.3mg/dL, serum creatinine of 1.2mg/dL,
and albumin of 3.1g/dL. Repeat echocardiogram with
agitated saline demonstrated excellent biventricular systolic
function, absence of tricuspid annular dilation, and late
(>5 cycles) right-to-left shunting suggesting a pulmonary
right-to-left shunt. The patient received empiric steroids for
possible idiopathic thrombocytopenic purpura after otherCase Reports in Medicine 3
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Figure 3: M-mode echo, parasternal short-axis, demonstrating
leftwarddisplacementoftheseptumduringdiastole(whitearrows),
consistent with right ventricular volume overload. Right ventricle
(RV), septum (S), left ventricle (LV), posterior wall (PW), and
pericardial eﬀusion (PEF).
etiologies were excluded, with improvement of her platelet
counts. The patient also developed recurrent atrial ﬂutter.
Because of her hyperbilirubinemia and thrombocytope-
nia, she was felt to be a poor candidate for lung trans-
plantation. It was concluded that without TV surgery, the
patient’s long-term outcome would be poor and that surgery
was indicated. The recommendation was buttressed by the
presence of normal RV systolic function with normal TV
tissueDoppler systolic annularvelocity(Figure 2(b))andthe
abrupt clinical deterioration suggesting sudden disruption
of valve integrity leading to poorly tolerated severe TR. The
patient was presented with the option of high-risk surgical
intervention and consented to TV surgery.
Two weeks later the patient underwent TV replacement.
Treprostinil was held immediately prior to surgery. Intra-
operative inspection of the TV revealed ruptured chor-
dae with a ﬂail, prolapsing anterior leaﬂet, and normal
annular size. A patent foramen ovale was not present.
Valve repair was not performed due to friability of the
subvalvular apparatus and concern regarding longevity of
repair given her pulmonary hypertension. A stented 27mm
Magna (Edwards Life Sciences) bioprosthesis was selected
for TV replacement. Right atrial MAZE cryoablation and
ligation of the left atrial appendage were also performed. PA
systolic pressure increased to 90mmHg postvalve replace-
ment (preintervention baseline 65mmHg). The patient was
successfully weaned from cardiopulmonary bypass on intra-
venous epinephrine, dopamine, milrinone, inhaled nitric
oxide (40 parts per million), and intravenous prostacyclin
(20ng/kg/min). Total cardiopulmonary bypass time was 106
minutes, and aortic cross-clamp time was 81 minutes.
Catheterization on postoperative day 1 demonstrated PA
pressure of 90/32mmHg and improved cardiac index of
2.7L/min/m2 and a pulmonary vascular resistance of 6.7
Wood units. Repeat echo demonstrated decreased RV size,
normal systolic function, and mild high pressure TR. She
was extubated on postoperative day 4 and discharged from
the intensive care unit 10 days postoperatively. She was
transitioned from intravenous prostacyclin to subcutaneous
treprostinil (20ng/kg/min) and oral sildenaﬁl (20mg twice
daily). She was discharged on postoperative day 15 on
the above medications as well as digoxin, prednisone,
spironolactone, bosentan, and furosemide. She was seen
in clinic three months postoperatively and had returned
to her baseline functional status (WHO class II). The
jaundice, ascites, hypoalbuminemia, RV failure, and liver
abnormalities had resolved.
2. Discussion
There is a paucity of data on the incidence, prevalence,
and prognosis of severe TR in patients with PAH not due
to elevated left heart ﬁlling pressures. It has long been
thought that TV surgery in patients with severe pulmonary
hypertension without mitral valve disease carried an unac-
ceptably high risk of mortality. This patient’s presentation is
not unique; although uncommon, tricuspid chordal rupture
can occur in patients with PAH. However, the use of
multiple clinical and imaging modalities to determine that
TV surgery without concomitant lung transplantation could
be successfully performed is novel.
The relatively sudden deterioration after a long period of
clinical stability was suspicious for an abrupt event leading
to right heart failure and hepatic dysfunction. Chronic TR
secondary to RV enlargement and systolic failure is more
likely to result in gradual functional decline. Absence of
RV systolic dysfunction or tricuspid annular dilation and
presence of a ﬂail leaﬂet all pointed to chordal rupture as
the index event leading to clinical deterioration. In patients
with implantable pacemakers and cardioverter-deﬁbrillators,
disruption of the tricuspid valve apparatus by the device lead
must also be considered [3].
Echocardiography with Doppler is a readily available,
cost-eﬀective, and accurate tool for the anatomic, hemody-
namic, and functional assessment of cardiopulmonary status
in patients with pulmonary hypertension [1, 2, 4, 5]. At
centers that do not employ tissue Doppler, tricuspid annular
plane systolic excursion (TAPSE) may be used to evaluate
right ventricular function [6]. Computed tomography and
magnetic resonance imaging can also provide an excellent
assessment of right ventricular size and function [7, 8].
Pulmonary vasodilator therapy in PAH is associated with
improvedqualityoflifeandfunctionalperformance[9].This
patient was managed with subcutaneous and intravenous
prostacyclin prior to, during, and following surgery. Both
phosphodiesterase inhibitions with sildenaﬁl and endothelin
antagonism with bosentan were utilized in this patient.
Perioperative mortality and morbidity risk is not low, and
diﬃcult intra- and postoperative courses are common in
patients with advanced PAH.
In conclusion, this report describes successful TV
replacement in a patient with severe PAH unrelated to mitral
valve disease presenting with severe RV failure and hepatic
dysfunction. Clinical and echocardiographic assessments
suggested that increased TR severity was secondary to abrupt4 Case Reports in Medicine
chordal rupture. RV systolic function and tricuspid annular
diameter were preserved, supporting the hypothesis that
TV competence would be well tolerated. Importantly, in
patients with signiﬁcantly impaired RV function, tricuspid
valve surgery carries an extremely high risk of mortality and
is generally contraindicated. Valve replacement was chosen
over valve repair given the absence of annular dilation, the
friable nature of the subvalvular apparatus, and the concern
regarding long term durability of valve repair given her
pulmonary hypertension. A bioprosthetic valve was selected
over a more durable mechanical prosthesis because of the
patient’s thrombocytopenia and the wish to avoid chronic
anticoagulation. The patient has done remarkably well in
the twelve months following surgery. However, the long-
term durability of a bioprosthetic valve in the tricuspid
position in a patient with severe pulmonary hypertension
is unclear. Finally, the availability of oral, subcutaneous,
inhaled, and intravenous pulmonary arterial vasodilators
in the current era, in addition to improved multimodality
diagnostic accuracy necessitates reconsideration of a long
discarded surgical option.
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